Yin Lichen, Ding Jieying, Fei Likun, He Miao, Cui Fuying, Tang Cui, Yin Chunhua
School of Life Sciences, Fudan University, Shanghai 200433, China.
Int J Pharm. 2008 Feb 28;350(1-2):220-9. doi: 10.1016/j.ijpharm.2007.08.051. Epub 2007 Sep 4.
In this investigation, superporous hydrogels containing poly (acrylic acid-co-acrylamide)/O-carboxymethyl chitosan (O-CMC) full-interpenetrating polymer networks (SPH-IPNs) were evaluated for their potentials in effective insulin absorption via the oral route. Insulin release from the SPH-IPNs exhibited sensitivity towards pH and ionic strength. After drug loading and release, the circular dichroism (CD) spectra revealed that conformation of insulin had no significant alteration and bioactivity of insulin was well preserved according to hypoglycaemic effect in mice. Through their abilities to bind Ca(2+) and to entrap the enzymes, SPH-IPNs could partly inactivate trypsin and alpha-chymotrypsin, and SPH-IPN with higher O-CMC/monomer ratio appeared more potent. Swollen SPH-IPNs could attach mechanically and muco-adhere to the intestinal wall, thus achieving improved retentive properties compared to commonly used muco-adhesive excipient Carbopol 934. Transport of insulin across rat intestine and colon ex vivo was enhanced around two- to three-fold after application of the SPH-IPN. Insulin-loaded SPH-IPN showed significant hypoglycaemic effects following oral administration to healthy rats, achieving a 4.1% pharmacological availability compared to subcutaneous insulin injection. These pronounced properties demonstrated that the SPH-IPN would be a promising peroral carrier for insulin and other peptide drugs.
在本研究中,对含有聚(丙烯酸 - 共 - 丙烯酰胺)/ O - 羧甲基壳聚糖(O - CMC)全互穿聚合物网络(SPH - IPNs)的超多孔水凝胶经口服途径有效吸收胰岛素的潜力进行了评估。胰岛素从SPH - IPNs中的释放表现出对pH值和离子强度的敏感性。载药和释药后,圆二色性(CD)光谱显示胰岛素的构象没有显著改变,并且根据小鼠的降血糖作用,胰岛素的生物活性得到了很好的保留。通过其结合Ca(2+)和截留酶的能力,SPH - IPNs可以部分使胰蛋白酶和α - 糜蛋白酶失活,并且具有较高O - CMC/单体比例的SPH - IPN表现出更强的活性。肿胀的SPH - IPNs可以机械附着并黏膜黏附于肠壁,因此与常用的黏膜黏附赋形剂卡波姆934相比,具有更好的滞留性能。应用SPH - IPN后,胰岛素在大鼠离体肠道和结肠的转运增强了约两到三倍。口服给予健康大鼠载胰岛素的SPH - IPN后显示出显著的降血糖作用,与皮下注射胰岛素相比,实现了4.1%的药理利用率。这些显著特性表明,SPH - IPN将是胰岛素和其他肽类药物有前景的口服载体。